News Search Results
Mar 13, 2025, 10:00 ET Coronado Research Announce the Appointment of Nick Littlebury as EVP, Regulatory Affairs
Coronado Research Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML,
More news about: Coronado Research
Mar 13, 2025, 09:37 ET Immorta Bio Presents SenoVax™ Mediated Tumor Remission Data at International Biotechnology Conference
multimedia:https://www.prnewswire.com/news-releases/immorta-bio-presents-senovax-mediated-tumor-remission-data-at-international-biotechnology-conference-302401123.html
More news about: Immorta Bio Inc.
Mar 13, 2025, 09:03 ET Duly Health Brings Genetic-Based Weight Loss Treatment to Chicago with MyPhenome Test
Phenomix Sciences (Phenomix), a precision medicine biotechnology company that uses data intelligence to treat obesity, today announces its
More news about: Phenomix Sciences
Mar 13, 2025, 09:00 ET Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality
With over 23 years of global expertise, Caliber continues to transform pharmaceutical and biotechnology companies with GxP Quality solutions across Quality Control, Quality Assurance, Manufacturing, and Data and Insights. These solutions help companies
More news about: Caliber Technologies
Mar 13, 2025, 09:00 ET Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation
the life sciences sector through flagship use cases. About Insilico Medicine Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, medicine and science research using next-generation AI systems. The company
More news about: Insilico Medicine
Mar 13, 2025, 09:00 ET UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Mar 13, 2025, 08:00 ET Blue Earth Therapeutics Reports Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial
Bracco family of companies. With proven management expertise across the spectrum of radiopharmaceutical and oncology drug development, as well as biotechnology start–up experience, the Company aims to innovate and improve upon current technologies and rapidly advance new targeted therapies for serious diseases.
More news about: Blue Earth Therapeutics Ltd
Mar 13, 2025, 07:30 ET Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced it has presented data evaluating the role
More news about: Virax Biolabs
Mar 13, 2025, 07:00 ET Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary
solution for cancer-related fatigue. About Canada Royal Enoch Phytomedicine Ltd.Canada Royal Enoch Phytomedicine Ltd. is a biotechnology company specializing in the research, production, and sales of natural plant-based health products. The company's flagship brand, Redsenol® (also
More news about: Canada Royal Enoch Phytomedicine Ltd.
Mar 13, 2025, 05:45 ET ICON Public Limited Company Class Action: The Gross Law Firm Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Mar 13, 2025, 05:00 ET Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality
With over 23 years of global expertise, Caliber continues to transform pharmaceutical and biotechnology companies with GxP Quality solutions across Quality Control, Quality Assurance, Manufacturing, and Data and Insights. These solutions help companies
More news about: Caliber Technologies
Mar 13, 2025, 04:00 ET Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
properties of individual microbes – an essential step toward developing biotechnology solutions, including tailored microbial treatments that naturally suppress harmful microbes. Receiving the 2025 Novonesis Biotechnology Prize not only honours Vorholt's work but also highlights its potential
More news about: Novo Nordisk Foundation
Mar 12, 2025, 20:21 ET Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences Announce Innovative PharmD-MBA Pathway Program
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Mar 12, 2025, 19:30 ET STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Mar 12, 2025, 17:31 ET ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight
(taletrectinib/AB-106/IBI-344) (Nuvation Bio/Innovent Biologics/Daiichi Sankyo/Nippon Kayaku), Zidesamtinib (NVL-520) (Nuvalent), ANS03 (Avistone Biotechnology), Zanidatamab (Jazz Pharmaceuticals), PT-112 (Promontory Therapeutics), and others. In December 2024,
More news about: DelveInsight Business Research, LLP
Mar 12, 2025, 17:08 ET Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva
March 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Mar 12, 2025, 16:15 ET Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
information and a PIN allowing them to access the live call. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Mar 12, 2025, 12:55 ET INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
MEETING, Pa., March 12, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Mar 12, 2025, 12:30 ET VITAMIN ANGELS APPOINTS GLOBAL HEALTH LEADER ANA CÉSPEDES AS CHIEF EXECUTIVE OFFICER
spearheading key initiatives in operational excellence and strategic growth. Prior to IAVI, Céspedes held senior leadership positions in pharmaceutical, biotechnology and strategic consulting sectors, including Lilly, Arthur Andersen, Serono and Merck KGaA, Darmstadt, Germany,
More news about: Vitamin Angels
Mar 12, 2025, 11:53 ET Urolithin A Market Grows Strongly with Rising Demand for Anti-Aging and Health Supplements | Valuates Reports
populations age and prioritize longevity-focused solutions, demand for Urolithin A supplements and therapeutics surges. Future advancements in biotechnology and personalized medicine will likely further elevate the market, securing Urolithin A's position as a crucial component in the evolving health
More news about: Valuates Reports
Mar 12, 2025, 10:30 ET Urinary Incontinence Devices Market worth US$7.97 billion by 2030 with 14.5% CAGR | MarketsandMarkets™
Investments at the levels that J&J makes over years guarantee a constant stream of innovation within the medical devices, pharmaceuticals, and biotechnology industries. These initiatives not only streamline its market approach but also ensure that it addresses landscape shifts in patient care with advanced
More news about: MarketsandMarkets
Mar 12, 2025, 10:08 ET PranaX Appoints Phillip Maderia as CEO to Lead Exosome Innovation
solidifying its role as a global leader in next-generation wellness. About PranaX CorporationPranaX is a regenerative medicine biotechnology company dedicated to harnessing stem cell-derived exosomes to rejuvenate aging, inflamed, and damaged tissues and organs through evidence-based
More news about: PranaX
Mar 12, 2025, 10:01 ET Clinical Trial Services Market worth US$101.86 billion by 2030 with 8.9% CAGR | MarketsandMarkets™
in the clinical trial service market offering services such as clinical development, patient access solutions, and consulting to pharmaceutical, biotechnology organizations, and medical device companies. The company's service portfolio includes comprehensive Phase I through IV clinical trial management,
More news about: MarketsandMarkets
Mar 12, 2025, 09:05 ET Shiru and GreenLab Partner to Scale Sustainable Protein Production Through Novel Corn-Based Expression System
ProteinDiscovery.ai for more. About GreenLabGreenLab's mission is to green industry through next-generation plant biotechnology. With GreenLab's platform, a cornfield is transformed into a factory of the future. GreenLab delivers on biotech's promise of next-generation proteins,
More news about: Shiru, Inc.
Mar 12, 2025, 08:47 ET GBI Biomanufacturing Announces Sven Lee as New Board Member
here to watch a short segment from our SME Series on Biologics Tech Transfer Process at GBI! About GBI Biomanufacturing (formerly Goodwin Biotechnology, Inc.) GBI is a premier Contract Development and Manufacturing Organization (CDMO) specializing in
More news about: GBI Biomanufacturing